1
|
García JIR, Oro V, Budd EL, Mauricio AM, Cioffi CC, Anda SD, McWhirter EH, DeGarmo DS, Leve LD. A Translational Case Study of a Multisite COVID-19 Public Health Intervention Across Sequenced Research Trials: Embedding Implementation in a Community Engagement Phased Framework. Am J Public Health 2024; 114:S396-S401. [PMID: 38776498 PMCID: PMC11111377 DOI: 10.2105/ajph.2024.307669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/22/2024] [Indexed: 05/25/2024]
Abstract
Through a COVID-19 public health intervention implemented across sequenced research trials, we present a community engagement phased framework that embeds intervention implementation: (1) consultation and preparation, (2) collaboration and implementation, and (3) partnership and sustainment. Intervention effects included mitigation of psychological distress and a 0.28 increase in the Latinx population tested for SARS-CoV-2. We summarize community engagement activities and implementation strategies that took place across the trials to illustrate the value of the framework for public health practice and research. (Am J Public Health. 2024;114(S5):S396-S401. https://doi.org/10.2105/AJPH.2024.307669).
Collapse
Affiliation(s)
- Jorge I Ramírez García
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Veronica Oro
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Elizabeth L Budd
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Anne Marie Mauricio
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Camille C Cioffi
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Stephanie De Anda
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Ellen Hawley McWhirter
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - David S DeGarmo
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| | - Leslie D Leve
- Jorge I. Ramírez García is with the University of Oregon, Prevention Science Institute, Eugene and the Oregon Research Institute, Springfield. Veronica Oro and Camille C. Cioffi are with the University of Oregon, Prevention Science Institute, Eugene. Ellen Hawley McWhirter is with the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Elizabeth L. Budd, Anne Marie Mauricio, David S. DeGarmo, and Leslie D. Leve are with the University of Oregon, Prevention Science Institute, Eugene and the Department of Counseling Psychology and Human Services, University of Oregon, Eugene. Stephanie De Anda is with the University of Oregon, Prevention Science Institute, Eugene and the Department of Special Education and Clinical Sciences, University of Oregon, Eugene
| |
Collapse
|
2
|
Volkov BB, Pulley C, Shlafer R. Addressing health disparities in the criminal legal system: Translational benefits, challenges, and facilitators of impactful research with incarcerated pregnant women. J Clin Transl Sci 2023; 7:e112. [PMID: 37250993 PMCID: PMC10225259 DOI: 10.1017/cts.2023.528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Revised: 03/13/2023] [Accepted: 04/04/2023] [Indexed: 05/31/2023] Open
Abstract
This in-depth analysis illuminates a translational journey of a community-university research collaboration that examined health disparities among incarcerated pregnant women and spanned the translational spectrum, with the initial collaboration in 2011 paving the way for consequent research grants, publications, practices, programs, and legislation passed years later. The case study utilized data from interviews with research stakeholders, institutional and governmental sources, peer-reviewed publications, and news stories. Identified research and translational challenges included cultural differences between research and prison system; the prison system's lack of transparency; politics of using and translating research to policy change; and issues of capacity, power, privilege, and opportunity when doing community-engaged research/science. Among the facilitators of translation were the Clinical and Translational Science Award and institutional support; engagement of key stakeholders and influencers; authentic collaboration and team science; researchers as translation catalysts; pragmatic scientific approach; and policies and legislative activities. The research contributed to a variety of community and public health, policy/legislative, clinical/medical, and economic benefits. The case study findings enhance our understanding of translational science principles and processes leading to improved wellbeing and serve as a call for advancing the research agenda addressing health disparities related to criminal and social justice issues.
Collapse
Affiliation(s)
- Boris B. Volkov
- Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
- Institute for Health Informatics and Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA
| | - Chris Pulley
- Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA
| | - Rebecca Shlafer
- Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
| |
Collapse
|
3
|
Brewer SK, Davis JM, Singh R, Welch LC. Establishing evidence-based pharmacologic treatments for neonatal abstinence syndrome: A retrospective case study. J Clin Transl Sci 2022; 6:e96. [PMID: 36003213 PMCID: PMC9393572 DOI: 10.1017/cts.2022.431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 06/09/2022] [Accepted: 07/19/2022] [Indexed: 11/07/2022] Open
Abstract
Translation of research discoveries into health impact can take many years, creating delays in improving clinical outcomes. One approach to promoting timely translation is to examine successful cases in order to understand facilitators and strategies for overcoming barriers. We examined the development of evidence-based management for neonatal abstinence syndrome (NAS) at one academic medical center, with a primary focus on pharmacologic treatment. Despite a substantial increase in NAS case incidence starting in the early 2000s, significant sociocultural, policy, and regulatory barriers limited collaborative NAS research. Facilitators for translation encompassed: 1) pursuing research of societal interest, 2) building an effective interdisciplinary team, 3) intentionally linking clinical, research, and advocacy efforts, 4) broad stakeholder engagement across clinical, policy, and research arenas, and 5) leveraging local resources. Challenges included lack of commercially available U.S. Food and Drug Administration approved neonatal drug formulations, legal and regulatory barriers related to off-label and illicit use of opioids, recruitment for a treatment associated with drug withdrawal syndromes, misalignment of research design needs with real-world scenarios, and episodic funding. Benefits of successful translation included improvements in clinical care, reduced healthcare costs related to NAS, and enhanced legislative, policy, and research strategies to support broader neonatal investigations.
Collapse
Affiliation(s)
- Sarah K. Brewer
- Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA
| | - Jonathan M. Davis
- Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA
- Tufts Medical Center, Boston, MA, USA
| | | | - Lisa C. Welch
- Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA
| |
Collapse
|
4
|
Samuels E, Champagne E, Gravelin M, Racklyeft J, Weatherwax K. Adapting an Expanded Access program to enable investigational treatments for COVID-19. J Clin Transl Sci 2022; 6:e77. [PMID: 35836783 PMCID: PMC9274384 DOI: 10.1017/cts.2022.403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 05/04/2022] [Accepted: 05/11/2022] [Indexed: 11/07/2022] Open
Abstract
Retrospective case studies of initiatives supported by the National Institutes of Health's Clinical and Translational Science Award (CTSA) hubs can be used to identify facilitators and barriers of translational science. This case study investigates how a CTSA Expanded Access program adapted to changing FDA guidance issued in 2020 to support clinicians' treatment of COVID-19 patients in Michigan. We studied how this program changed throughout the pandemic to support physicians' requests for remdesivir, convalescent plasma, and other uses of unapproved drugs and novel medical devices. A protocol for retrospective translational science case studies of health interventions developed by CTSA evaluators was used for this case study. Data collection methods included seven interviews and a review of institutional data, peer-reviewed publications, news stories, and other public records. The barriers identified include evolving guidance, misalignment of organizational operations, and the complexity of the research infrastructure. The facilitators of translation include collaboration between research and care teams, increasing engagement with a broad network of supporters, and ongoing professional development for research staff. The findings of this case study can be used to inform future investigations of the principles underlying the translational process.
Collapse
Affiliation(s)
- Elias Samuels
- Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, MI, USA
| | - Ellen Champagne
- Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, MI, USA
| | - Misty Gravelin
- Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, MI, USA
| | - Jamie Racklyeft
- Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, MI, USA
| | - Kevin Weatherwax
- Michigan Institute for Clinical & Health Research, University of Michigan, Ann Arbor, MI, USA
- College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
5
|
Padilla-Cabello J, Santisteban-Espejo A, Heradio R, Cobo MJ, Martin-Piedra MA, Moral-Munoz JA. Methods for identifying biomedical translation: a systematic review. Am J Transl Res 2022; 14:2697-2708. [PMID: 35559386 PMCID: PMC9091120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 12/30/2021] [Indexed: 06/15/2023]
Abstract
Translational medicine is an important area of biomedicine, and has significantly facilitated the development of biomedical research. Despite its relevance, there is no consensus on how to evaluate its progress and impact. A systematic review was carried out to identify all the methods to evaluate translational research. Seven methods were found according to the established criteria to analyze their characteristics, advantages, and limitations. They allow us to perform this type of evaluation in different ways. No relevant advantages were found between them; each one presented its specific limitations that need to be considered. Nevertheless, the Triangle of Biomedicine could be considered the most relevant method, concerning the time since its publication and usefulness. In conclusion, there is still a lack of a gold-standard method for evaluating biomedical translational research.
Collapse
Affiliation(s)
- Javier Padilla-Cabello
- Program of Biomedicine, University of GranadaGranada, Spain
- Department of Otorhinolaryngology, Hospital Universitario Clínico San CecilioGranada, Spain
| | - Antonio Santisteban-Espejo
- Department of Pathology, Puerta del Mar University HospitalCadiz, Spain
- Institute of Research and Innovation in Biomedical Sciences of The Province of Cadiz (INiBICA)Cadiz, Spain
| | - Ruben Heradio
- School of Computer Science, Universidad Nacional de Educación a Distancia (UNED)Madrid, Spain
| | - Manuel J Cobo
- Department of Computer Science and Engineering, University of CadizPuerto Real, Spain
| | | | - Jose A Moral-Munoz
- Institute of Research and Innovation in Biomedical Sciences of The Province of Cadiz (INiBICA)Cadiz, Spain
- Department of Nursing and Physiotherapy, University of CadizCadiz, Spain
| |
Collapse
|
6
|
Faupel-Badger JM, Vogel AL, Hussain SF, Austin CP, Hall MD, Ness E, Sanderson P, Terse PS, Xu X, Balakrishnan K, Patnaik S, Marugan JJ, Rudloff U, Ferrer M. Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences. J Clin Transl Sci 2022; 6:e66. [PMID: 35754433 PMCID: PMC9201875 DOI: 10.1017/cts.2022.374] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 03/02/2022] [Accepted: 03/04/2022] [Indexed: 11/06/2022] Open
Abstract
There are numerous examples of translational science innovations addressing challenges in the translational process, accelerating progress along the translational spectrum, and generating solutions relevant to a wide range of human health needs. Examining these successes through an education lens can identify core principles and effective practices that lead to successful translational outcomes. The National Center for Advancing Translational Sciences (NCATS) is identifying and teaching these core principles and practices to a broad audience via online courses in translational science which teach from case studies of NCATS-led or supported research initiatives. In this paper, we share our approach to the design of these courses and offer a detailed description of our initial course, which focused on a preclinical drug discovery and development project spanning academic and government settings. Course participants were from a variety of career stages and institutions. Participants rated the course high in overall value to them and in providing a unique window into the translational science process. We share our model for course development as well as initial findings from the course evaluation with the goal of continuing to stimulate development of novel education activities teaching foundational principles in translational science to a broad audience.
Collapse
Affiliation(s)
- Jessica M. Faupel-Badger
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Amanda L. Vogel
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Shadab F. Hussain
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | | | - Matthew D. Hall
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Elizabeth Ness
- National Institutes of Health, National Cancer Institute, Bethesda, MD, USA
| | - Philip Sanderson
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Pramod S. Terse
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Xin Xu
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Krishna Balakrishnan
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Samarjit Patnaik
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Juan J. Marugan
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| | - Udo Rudloff
- National Institutes of Health, National Cancer Institute, Bethesda, MD, USA
| | - Marc Ferrer
- National Institutes of Health, National Center for Advancing Translational Sciences, Bethesda, MD, USA
| |
Collapse
|
7
|
Qua K, Swiatkowski SM, Gurkan UA, Pelfrey CM. A retrospective case study of successful translational research: Gazelle Hb variant point-of-care diagnostic device for sickle cell disease. J Clin Transl Sci 2021; 5:e207. [PMID: 35047218 PMCID: PMC8727719 DOI: 10.1017/cts.2021.871] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Revised: 10/19/2021] [Accepted: 10/19/2021] [Indexed: 11/06/2022] Open
Abstract
Evaluation researchers at Clinical and Translational Science Award (CTSA) hubs are conducting retrospective case studies to evaluate the translational research process. The objective of this study was to deepen knowledge of the translational process and identify contributors to successful translation. We investigated the successful translation of the HemeChip, a low-cost point-of-care diagnostic device for sickle cell disease, using a protocol for retrospective translational science case studies of health interventions developed by evaluators at the National Health Institutes (NIH) and CTSA hubs. Development of the HemeChip began in 2013 and evidence of device use and impact on public health is growing. Data collection methods included five interviews and a review of press, publications, patents, and grants. Barriers to translation included proving novelty, manufacturing costs, fundraising, and academic-industry relations. Facilitators to translation were CTSA pilot program funding, university resources, entrepreneurship training, due diligence, and collaborations. The barriers to translation, how they were overcome, and the key facilitators identified in this case study pinpoint areas for consideration in future funding mechanisms and the infrastructure required to enable successful translation.
Collapse
Affiliation(s)
- Kelli Qua
- Clinical and Translational Science Collaborative, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
| | - Shannon M. Swiatkowski
- Clinical and Translational Science Collaborative, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
| | - Umut A. Gurkan
- Department of Mechanical and Aerospace Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH, USA
- Department of Biomedical Engineering, Case School of Engineering, Case Wetern Reserve University, Cleveland, OH, USA
- Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA
| | - Clara M. Pelfrey
- Clinical and Translational Science Collaborative, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
| |
Collapse
|